Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$29 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0755
D

Failure to Document Monitoring for Anticoagulant and Insulin Therapy

Scottsburg, Indiana Survey Completed on 03-18-2026

Penalty

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

The deficiency involves the facility’s failure to ensure appropriate monitoring and documentation for residents receiving anticoagulant and insulin therapy, as required by its medication administration policy. For one resident with diabetes and a history of left above-knee amputation, admission orders included aspirin 81 mg daily, Xarelto 20 mg daily with breakfast, and insulin lispro 5 units subcutaneously with meals. Review of this resident’s medication administration records for January, February, and March 2026 showed no documentation that nursing staff monitored for signs or symptoms of bleeding related to the blood thinners or for signs or symptoms of hypoglycemia or hyperglycemia related to the insulin. Another resident with diabetes had an order for Lantus 25 units subcutaneously twice daily at 9:00 a.m. and 9:00 p.m., but the clinical record lacked documentation that nursing staff monitored for signs or symptoms of hyperglycemia or hypoglycemia. Two additional residents receiving anticoagulant therapy also lacked documented monitoring for bleeding. One resident with chronic embolism and thrombosis of the right upper extremity had an order for apixaban 5 mg twice daily at 8:00 a.m. and 8:00 p.m., yet the clinical record showed no documentation of bleeding assessments from March 12 through March 16, 2026. Another resident with hypotension and cardiovascular disease had an order for apixaban 5 mg twice daily at 8:00 a.m. and 8:00 p.m. for cardiovascular health, but the record similarly lacked documentation of monitoring for signs of bleeding. During an interview, an LPN confirmed that residents on blood thinners should be monitored for signs of bleeding and residents on insulin should be monitored for hyperglycemia and hypoglycemia, and that such monitoring should be documented on the medication administration record. The facility’s Medication Administration Policy Guideline stated that medications are to be administered as prescribed and in accordance with good nursing principles and practices.

Long-term care team reviewing survey readiness and plan of correction

We Help Long-Term Care Teams Stay Survey-Ready

We process and analyze inspection reports and plan of correction using AI to extract insights and trends so providers can improve care quality and stay ahead of compliance risks.

Discover our solutions:

An unhandled error has occurred. Reload 🗙